We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

212 hedge funds and large institutions have $1.45B invested in Corcept Therapeutics in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 66 increasing their positions, 68 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 32

12% more funds holding

Funds holding: 190 → 212 (+22)

10% more call options, than puts

Call options by funds: $10.8M | Put options by funds: $9.82M

3% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 68

1.33% less ownership

Funds ownership: 77.88% → 76.55% (-1.3%)

10% less capital invested

Capital invested by funds: $1.61B → $1.45B (-$159M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
212
Holders Change
+22
Holders Change %
+11.58%
% of All Funds
4.86%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
57
Increased
66
Reduced
68
Closed
32
Calls
$10.8M
Puts
$9.82M
Net Calls
+$1.02M
Net Calls Change
-$1.53M

Top Buyers

1
BlackRock
BlackRock
New York
+$27.9M
2
NC
Nexthera Capital
New York
+$19.4M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$15.4M
4
Deutsche Bank
Deutsche Bank
Germany
+$10.3M
5
Norges Bank
Norges Bank
Norway
+$8.82M

Top Sellers

1
Prudential Financial
Prudential Financial
New Jersey
-$23.4M
2
JIM
Jupiter Investment Management
United Kingdom
-$17.1M
3
BIM
Bogle Investment Management
Massachusetts
-$12.7M
4
TA
Teachers Advisors
New York
-$11.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$11.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$8.07M +$180K +9,739 +2%
Norges Bank
27
Norges Bank
Norway
$7.83M +$8.82M +475,761 New
ORI
28
Oak Ridge Investments
Illinois
$7.26M -$2.22M -119,886 -21%
EIM
29
Essex Investment Management
Massachusetts
$7.15M -$261K -14,088 -3%
Prudential Financial
30
Prudential Financial
New Jersey
$7.07M -$23.4M -1,265,290 -75%
STB
31
S&T Bank
Pennsylvania
$7.01M +$7.9M +426,257 New
American Century Companies
32
American Century Companies
Missouri
$7.01M +$9.78K +528 +0.1%
TCIM
33
TIAA CREF Investment Management
New York
$5.97M -$2.09M -112,928 -24%
Fidelity Investments
34
Fidelity Investments
Massachusetts
$5.81M – – –
AQR Capital Management
35
AQR Capital Management
Connecticut
$5.72M -$6.73M -363,267 -51%
TA
36
Teachers Advisors
New York
$5.46M -$11.5M -620,635 -65%
Squarepoint
37
Squarepoint
New York
$5.39M +$5.52M +297,864 +1,002%
MWNA
38
Marshall Wace North America
New York
$5.29M +$5.95M +321,264 New
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.79M +$1.01M +54,263 +23%
DA
40
Denali Advisors
California
$4.05M -$497K -26,800 -10%
TCM
41
Timpani Capital Management
Wisconsin
$4.04M +$1.53M +82,685 +51%
GC
42
Guggenheim Capital
Illinois
$3.92M +$506K +27,324 +13%
Citadel Advisors
43
Citadel Advisors
Florida
$3.84M +$3.66M +197,673 +556%
JP Morgan Chase
44
JP Morgan Chase
New York
$3.75M +$956K +51,576 +29%
AllianceBernstein
45
AllianceBernstein
Tennessee
$3.66M -$467K -25,180 -10%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$3.54M -$361K -19,500 -8%
AWS
47
AJ Wealth Strategies
New York
$3.4M +$1.31M +70,500 +52%
PPA
48
Parametric Portfolio Associates
Washington
$3.29M +$714K +38,548 +24%
Legal & General Group
49
Legal & General Group
United Kingdom
$3.18M +$417K +22,531 +13%
GCP
50
GSA Capital Partners
United Kingdom
$3.16M +$1.96M +105,600 +122%
1
2
3 4 5

CORT Hedge Fund Activity: Q1 2018 in Review

212 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q1 2018, worth a combined $1.45B — down 9.9% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new CORT positions and 32 closed out — a net gain of 25 holders — while 66 added to existing stakes and 68 trimmed.

The largest buyer was BlackRock, adding an estimated $27.9M. The largest seller was Prudential Financial, cutting an estimated $23.4M.

  • 212 institutional investors held Corcept Therapeutics (CORT) as of Q1 2018, up from 190 in Q4 2017.
  • Funds reported $1.45B of Corcept Therapeutics stock for Q1 2018, down 9.9% quarter-over-quarter.
  • 57 funds opened new Corcept Therapeutics positions in Q1 2018 and 32 closed out, a net change of +25 holders.
  • The largest Corcept Therapeutics buyer in Q1 2018 was BlackRock, an estimated $27.9M added.
  • The largest Corcept Therapeutics seller in Q1 2018 was Prudential Financial, an estimated $23.4M sold.

Based on aggregated 13F filings for Q1 2018.